EUVIMEDEUVIMED entdecken
Crossref

Role of [18F]FDG PET/CT in Detection and Therapeutic Management of Vascular Graft Infections in Marfan Patients

B Levita, H Grubitzsch, S Buz, V Falk, I Hilgendorf, T D Trippel, M Galler, G Metzger, J Rogasch, W Brenner, H Amthauer, P Gehle und 1 weitere

Nuklearmedizin - NuclearMedicine · 01.04.2026 · 65 (02) · 162-163

DOI: 10.1055/s-0046-1818340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nuklearmedizin - NuclearMedicine, erschienen am 01.04.2026. Verfasst von B Levita und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ziel/Aim: Vascular graft infections (VGI) are associated with significant mortality, and their clinical management presents a substantial challenge, particularly due to the need for early diagnosis. This study aimed to assess the diagnostic performance and potential therapeutic impact of 18F-FDG PET/CT in comparison with contrast-enhanced CT (CE-CT) in outpatients with Marfan syndrome (MFS) presenting with suspected vascular graft infection. Methodik/Methods: 18F-FDG PET/CT and CE-CT examinations were retrospectively evaluated in 26 patients with MFS presenting with clinically suspected VGI. For 18F-FDG PET/CT, diagnostic performance was analyzed based on maximum standardized uptake value (SUVmax) in the periprosthetic region and metabolic active infection volume (MAIV) using a threshold-based approach. A multimodal reference standard incorporating clinical, laboratory, microbiological, and imaging findings confirmed the final diagnosis. Ergebnisse/Results: Metabolically active VGI on 18F-FDG PET/CT occurred in 24 of 26 patients (92.3%), with a median SUVmax of 6.2 (IQR 5.1–8.5) and a MAIV of 28.6 cm³ (IQR 15.2–46.4). Patients with Dacron vascular grafts tended to exhibit higher SUVmax values than those with other graft materials. The sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), and overall accuracy of 18F-FDG PET/CT were 100%, each, thus, outperforming CE-CT, which showed corresponding values of 25%, 100%, 6.3%, 100%, and 28.6%. Median C-reactive protein (CRP) was 3.8 mg/l (95% CI 1.8–12.7), and median white blood cell count (WBC) was 7.6/nl (95% CI 6.1–8.7). Neither parameter correlated with SUVmax or MAIV. Oral antibiotic therapy was escalated or continued based on 18F-FDG PET/CT examinations despite normal CRP and WBC values in 70.8% (17 of 24 patients), reflecting its superior sensitivity and the fact that infection parameters may remain normal in chronic or low-grade infections. Schlussfolgerungen/Conclusion: 18F-FDG PET/CT accurately detected vascular graft infections in Marfan patients and is significantly superior to contrast-enhanced CT, with substantial therapeutic impact even when infection parameters are not indicative. Publication History Article published online: 02 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Levita, B., Grubitzsch, H., Buz, S., Falk, V., Hilgendorf, I., Trippel, T. D., Galler, M., Metzger, G., Rogasch, J., Brenner, W., Amthauer, H., Gehle, P., & Furth, C. (2026). Role of [18F]FDG PET/CT in Detection and Therapeutic Management of Vascular Graft Infections in Marfan Patients. Nuklearmedizin - NuclearMedicine, 65(02), 162-163. https://doi.org/10.1055/s-0046-1818340

Vancouver

Levita B, Grubitzsch H, Buz S, Falk V, Hilgendorf I, Trippel TD, et al. Role of [18F]FDG PET/CT in Detection and Therapeutic Management of Vascular Graft Infections in Marfan Patients. Nuklearmedizin - NuclearMedicine. 2026;65(02):162-163. doi:10.1055/s-0046-1818340

BibTeX
@article{Levita2026,
  author = {Levita, B and Grubitzsch, H and Buz, S and Falk, V and Hilgendorf, I and Trippel, T D and Galler, M and Metzger, G and Rogasch, J and Brenner, W and Amthauer, H and Gehle, P and Furth, C},
  title = {Role of [18F]FDG PET/CT in Detection and Therapeutic Management of Vascular Graft Infections in Marfan Patients},
  journal = {Nuklearmedizin - NuclearMedicine},
  year = {2026},
  volume = {65},
  number = {02},
  pages = {162--163},
  doi = {10.1055/s-0046-1818340}
}
Kostenlos starten →